Quick Takeaways
- Gregory J. Flesher has 1 issuer position tracked on this page.
- Estimated disclosed ownership value: $722,961.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Gregory J. Flesher
- Location
- Irvine, CA
- Summary
- The estimated net worth of Gregory J. Flesher is at least $722,961 dollars as of 13 Dec 2022. Gregory J. Flesher is the President and CEO, Director of Reneo Pharmaceuticals, Inc. and owns shares of OnKure Therapeutics, Inc. (OKUR) stock worth about $723K.
- Signature
- /s/ Jennifer P. Lam, Attorney-in-Fact
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Gregory J. Flesher and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: Reneo Pharmaceuticals, Inc. ($722,961).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Gregory J. Flesher
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| OKUR | Reneo Pharmaceuticals, Inc. | President and CEO, Director | $722,961 | 09 Dec 2022 |
Insider Transactions Reported by Gregory J. Flesher:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.